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Chapter 7
Sut' luenY AND GENERAL DrscussroN
I rvould like to take the opportunity to surnmarize all findin-es and put these into
perspective In this thesis, we have studied the possible role of Staphyktcoccus eureus
in the pathophysiology of Wegener's granulomatosis (WG). As described in Chapter
I, Friedrich Wegener was the first to suggest an infectious etiology for WG The
pathophysiology of WG is still unknown today. Evidence shows that the majority of
patients with WG are chronic nasal carriers of S. aureus, a serious risk factor for
developing a relapse of the disease. Due to chronic S. aureus carriage/subclinical
infbctions, cationic antigens such as SAcP could enter the bloodstream and bind to
negatively charged structures on endothelial cells. Antibodies directed against SAcP,
present in the plasma of patients with WG, may bind to SAcP resulting in the
formation of immune complexes. SAcP could also be responsible for the formation of
circulating immune cornplexes once it enters the blood stream and comes in contact
with anti-SAcP antibodies. These circulating immune complexes can subsequently
deposits in organs resulting in inflammation. Should SAcP be involved in the
pathogenesis of WG this disease might not be as "pauci-immune" as is currently
believed. In this thesis we have tried to supply evidence that S. aureu.r play an
important role in the pathophysiology of WG and that it might not be a true "pauci-
immune" ANCA-associated vasculitis. We focussed our efforts on a cationic protein of
S. aureus, staphylococcal acid phosphatase (SAcP) as cationic proteins have been
found in renal biopsies of patients suffering from acute post-streptococcal
glomerulonephritis.
To test the hypothesis that SAcP can act as a planted antigen in WG. we studied the
ability of SAcP to bind to human umbilical vein endothelial cells (HUVEC) and human
glomerular endothelial cells Chapter 2 describes that SAcP can act as a planted
antigen by binding to both types of endothelial cells in a concentration-dependent
manner Binding of concentrations as low as 4 p,flml can be detected on HUVEC
within 5 minutes following incubation. Binding of SAcP to endothelial cells was
charge-dependent and did not activate endothelial cells This seems to rule out an
interaction with a receptor. Finally, endothelial cell-bound SAcP was recognized by
antibodies present in sera of patients with WG The data suggest a possible pathogenic
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role for SAcP by acting as a planted antigen thereby initiating glomerulonephritis and
vasculitis in patients with WG This would imply that immune complexes could play a
role in the pathogenesis of WG.
Immune complexes can either be deposited from the circulation or formed in situ inlhe
kidney and cause an immune complex-mediated glomerulonephritis. In Chapter 3 we
developed an animal model for S. aureus-associated glomerulonephritis Brown
Norway rats were immunized with SAcP or control-immunized with phosphate-
buffered saline. Fourteen days later, glomerulonephritis was evoked by unilateral
perfusion of the left kidney using different concentrations of SAcP (0, 10.25, 50 and
100 pglml). After 10 days, the rats were sacrificed and renal sections were stained for
the presence of inflammatory cells and immune deposits. ln animals that were sham-
immunized and perfused with 100 pg/ml SAcP and in the animals the were immunized
with SACP but perfused with PBS no abnormalities were observed in the kidney.
SAcp-immunized animals perfused with SAcP developed proteinuria due to crescentic
glomerulonephritis with influx of neutrophils and monocltes and immune deposits
(IgG and C3) Findings were dose-related as increases in SAcP concentration resulted
in increased damage Perfusions of l0 pglml SAcP induced mild glomerulonephritis
whereas perfusions of > 25 pdml SAcP were accompanied by severe
glomerulonephritis. ln conclusion, this animal model for S. aureus-associated. immune
complex-mediated glomerulonephritis could be useful for further understanding of this
form of infection-related glomerulonephritis
As described earlier, WG is considered a pauci-immune systemic vasculitis based
mainly on the absence of immune deposits in renal biopsies of patients with active
disease. In animal models of ANCA-associated glomerulonephritis immune deposits
can be detected along the glomerular capillary wall at early stages of lesion
development. lf ANCA-induced neutrophil activation is indeed responsible for the
rapid removal of immune complexes, these may still be detected in very early lesions in
patients with WG. Chapter 4 details, therefore. our efforts to detect immune deposits
in skin biopsies from patients with WG, taken within 48 hrs of lesion development
Using direct immunofluorescence, 32 skin biopsies were examined for the presence of
immune deposits (IgG, IgA, lgM, C3c). When possible. a comparison was made
between the immunofluorescence findings in renal and skin biopsies taken at the same
l 0 t
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time. Four out of I I biopsies taken at initial presentation of the disease and 4 out of 2l
biopsies taken at the onset of a relapse of WG showed IgG and/or lgA-containing
immune deposits in sub-epidermal blood vessels. All renal biopsies taken at the same
time showed pauci-immune glornerulonephritis rrespective of the presence (n-5) or
absence (n:4) of imrnune deposits in the skin biopsy Hence. a substantial number o1'
skin biopsies howed immune deposits during active disease. This is compatible with a
role for immune complexes in lesion development.
These results, however, do not confirm thar S. aureu.r is involved in these immune
deposits. ln order to prove that S. aureu.; is involved in imnrune complex tbrmation in
patients with WG, antibodies to its antigens need to be present Chapter 5 describes
our experiments on detection of antibodies to SAcP in blood from patients with WG
and detection of S. uureus antigens in renal biopsies of patients with WG. Sixty-one
plasma samples of WG patients were examined for the presence of antibodies directed
against staphylococcal acid phosphatase (o-SAcP). Anti-SAcP antibodies were
elevated at the time patients show signs of the disease for the first tirne (initial disease
manifestation). During a relapse or remission these antibodies are not elevated
anymore, possibly due to antibiotic treatment or the fact that physicians are quicker to
recognize a relapse and respond accordingly. We also studied the presence of SAcP in
renal biopsies of patients with WG. The presence of SAcP was detected in 3 out of l9
renal biopsies taken from patients with WG but not in 24 renal biopsies taken from
disease controls. Hence, glornerulonephritis may start as an immune complex mediated
disease involving staphylococcal antigens in at least a subset of patients with WG. ln
Chapter 6, we review current literature with respect o the hypothesis that ANCA-
associated vasculitides, particularly WG, may start as an immune cornplex mediated
disease. We hypothesize that the paucity of immune deposits in lesions of these
patients is because these are rapidly cleared due to the presence of ANCA Neutrophils
are attracted to and activated by the immune deposits thereby releasing their reactive
oxygen species (ROS) and lytic enzymes uch as myeloperoxidase (MPO), proteinase 3
(PR3) and human leukoclte elastase (HLE) all of which are anti-neutrophil
cltoplasmic antibody (ANCA) antigens ANCA binds to these ANCA antigens. thus
exxagerating the neutrophil response. resulting in increased release of ROS and lytic
enzymes This leads to rapid renroval of immune deposits. ultimately resulting in a
t02
clinical picture that i
decades everal studir
skin and renal lesionr
such as Churg Strausr
ln this thesis we p
pathogenesis of WG
in this hypothesis. In<
with WG showing thz
against SAcP can be I
immune complexes c,
actrng as a planted anr
has been detected in r,
be the result of immur
demonstrates that S
crescentic glomerulonr
There are trvo ways i
complexes can be forn
in .situ within an orgar
be "transported" to thi





.rlta in tissues. Studies
WG I l -5]  Since rhese
presence of circulating
patients. We also foun
lmmune complexes (un
not known.
It remains to be furth
jase and 4 out of 2l
lior IgA-containing
s taken at the same
j presence (n:5) or
,bstantial number of
is compatible with a
ed in these immune
omplex formation in
Jhapter 5 describes





s are not elevated
cians are quicker to
)resence of SAoP in
ected in 3 out of 19
riopsies taken from
: complex mediated
Ltrents with WG. In
thesis that ANCA-
complex mediated






of ROS and lytic
tely resulting in a
Summary and discussion
clinical picture that is consistent with a pauci-immune vasculitis lndeed. in the past
decades everal studies have described the presence of immune deposits in pulmonary,
skin and renal lesions of patients with WG and other ANCA-associated vasculitides,
such as Churg Strauss yndrome.
ln this thesis we presented the hypothesis that S. aureu.s plays a role in the
pathogenesis of WG. The possible formation of immune complexes plays a major part
in this hypothesis. lndeed, immune deposits can be detected in skin lesion of patients
with WG showing that WG is not as pauci-imrnune as is believed Antibodies directed
against SAcP can be found in plasma of patients raising the possibility that circulating
immune complexes could be formed. SAcP can bind to endothelial cells potentially
acting as a planted antigen and causing in .situ intmune complex formation SAcP itself
has been detected in renal biopsies of patients, indicating that glomerulonephritis could
be the result of immune cornplex fbrmation in the kidney. And finally, the animal model
demonstrates that SAcP is capable of inducing an immune complex-mediated
crescentic glomerulonephrit is
There are two ways in which immune complexes can be tbrmed; circulating immune
complexes can be formed in the blood circulation. or imrnune complexes can be formed
in situ wilhin an organ. The presence of SAcP in renal biopsies shows that SAcP can
be "transported" to this organ. The way in which this "transport" occurs is not known.
ln a pilot study using FACS we demonstrated that exogenous addition of SAcP to
neutrophils of healthy donors. resulted in the binding of SAcP to neutrophils
(unpublished data). We were unable to dernonstrate he presence of circulating SAcP-
loaded neutrophils in blood obtained from patients with WG The question remains
whether these immune complexes are deposited from the circulation or are formed }l
.rlftz in tissues. Studies have described the presence of circr,rlating irnmune complexes in
WG [-5] Since these studies were not performed recentlv. lve decided to study the
presence of circulating immune complexes in serum of untreated. newly diagnosed WG
patients. We also found that out of 9 sera tested. 5 had elevated levels of circulating
immune complexes (unpublished data) The involvement of SAcP in these complexes i
not known.
It remains to be further evah.rated which role ANCA plays in the rapid renroval of
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immune complexes. Our animal model, described in chapter 3, is not a true model for
WG since immune deposits can be detected in renal lesions. In chapter I we proposed
a mechanism for the rapid removal of immune complexes in WG. Due to the presence
of ANCA, immune deposits can be removed quickly (fig. I of the introduction). We
have, therefore, tried to develop the same model using rats whch were not only
immunized with SAcP but also with human myeloperoxidase (hMPO). Heeringa et al.
immunized rats with hMPO and showed that antibodies were formed after 14 days that
cross-reacted with rat MPO (rMPO) [6] Unfortunately, we were unable to reproduce
these results. All rats developed antibodies directed against hMPO but these antibodies
did not cross-react with rMPO We were, therefore. unable to confirm the proposed
hypothesis describing that the presence of ANCA increases the speed in which immune
complexes are removed.
ln conclusion, this study questions the paucity of immunoglobulin deposits in early
lesions of patients with WG S. uureus, and in particular its cationic protein SAoP,
could be a causal agent in the development of immune complexes in this disease.
However, at present, the data supporting this claim is insufficient o prove a causal
relationship
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